128 related articles for article (PubMed ID: 3234246)
1. The influence of brain catecholamines on 'drug taking behaviour' relative to oral self-administration of d-amphetamine by rats.
Kongyingyoes B; Jänicke B; Coper H
Drug Alcohol Depend; 1988 Dec; 22(3):223-33. PubMed ID: 3234246
[TBL] [Abstract][Full Text] [Related]
2. Tyrosine influence on amphetamine self-administration and brain catecholamines in the rat.
Geis LS; Smith DG; Smith FL; Yu DS; Lyness WH
Pharmacol Biochem Behav; 1986 Nov; 25(5):1027-33. PubMed ID: 3786355
[TBL] [Abstract][Full Text] [Related]
3. Long-term decreases in striatal dopamine, 3,4-dihydroxyphenylacetic acid, and homovanillic acid after a single injection of amphetamine in iprindole-treated rats: time course and time-dependent interactions with amfonelic acid.
Steranka LR
Brain Res; 1982 Feb; 234(1):123-36. PubMed ID: 7059818
[TBL] [Abstract][Full Text] [Related]
4. Effects of catecholamine depleting drugs and d-amphetamine on self-stimulation of the substantia nigra and locus coeruleus.
Cooper BR; Konkol RJ; Breese GR
J Pharmacol Exp Ther; 1978 Mar; 204(3):592-605. PubMed ID: 24729
[TBL] [Abstract][Full Text] [Related]
5. Effects of antipsychotic drugs on the long-term effects of amphetamine on nigro-striatal dopamine neurons in iprindole-treated rats.
Steranka LR
Naunyn Schmiedebergs Arch Pharmacol; 1984 Mar; 325(3):198-204. PubMed ID: 6145099
[TBL] [Abstract][Full Text] [Related]
6. Stimulus effects of d-amphetamine II: DA, NE, and 5-HT mechanisms.
West WB; Van Groll BJ; Appel JB
Pharmacol Biochem Behav; 1995 May; 51(1):69-76. PubMed ID: 7617735
[TBL] [Abstract][Full Text] [Related]
7. Effect of D-amphetamine on the extracellular concentrations of glutamate and dopamine in iprindole-treated rats.
Nash JF; Yamamoto BK
Brain Res; 1993 Nov; 627(1):1-8. PubMed ID: 7904885
[TBL] [Abstract][Full Text] [Related]
8. Amphetamine-induced enhancement of ethanol consumption: role of central catecholamines.
Levy AD; Ellison G
Psychopharmacology (Berl); 1985; 86(1-2):233-6. PubMed ID: 3927362
[TBL] [Abstract][Full Text] [Related]
9. Depletion of catecholamines in the brain of rats differentially affects stimulation of locomotor activity by caffeine, D-amphetamine, and methylphenidate.
Finn IB; Iuvone PM; Holtzman SG
Neuropharmacology; 1990 Jul; 29(7):625-31. PubMed ID: 1974712
[TBL] [Abstract][Full Text] [Related]
10. Amphetamine-induced perseverative behavior in a radial arm maze following DSP4 or 6-OHDA pretreatment.
Bruto V; Beauchamp C; Zacharko RM; Anisman H
Psychopharmacology (Berl); 1984; 83(1):62-9. PubMed ID: 6429702
[TBL] [Abstract][Full Text] [Related]
11. Catecholamines and operant response rates in albino rats.
Will B; Maurissen J; Ropartz P
Psychopharmacol Commun; 1976; 2(3):219-29. PubMed ID: 996277
[TBL] [Abstract][Full Text] [Related]
12. Depletion of brain serotonin following intra-raphe injections of 5,7-dihydroxytryptamine does not alter d-amphetamine self-administration across different schedule and access conditions.
Fletcher PJ; Korth KM; Chambers JW
Psychopharmacology (Berl); 1999 Sep; 146(2):185-93. PubMed ID: 10525754
[TBL] [Abstract][Full Text] [Related]
13. Effects of D-amphetamine and phencyclidine on behavior and extracellular concentrations of neurotensin and dopamine in the ventral striatum and the medial prefrontal cortex of the rat.
Hertel P; Mathé JM; Nomikos GG; Iurlo M; Mathé AA; Svensson TH
Behav Brain Res; 1995 Dec; 72(1-2):103-14. PubMed ID: 8788863
[TBL] [Abstract][Full Text] [Related]
14. P-hydroxy-norephedrine as a possible mediator causing the reduction of oral intake of D-amphetamine in rats.
Jänicke B; Heil T; Coper H
Drug Alcohol Depend; 1989 Jun; 23(3):247-53. PubMed ID: 2752916
[TBL] [Abstract][Full Text] [Related]
15. Responsiveness to d-amphetamine in lead-exposed rats as measured by steady state levels of catecholamines and locomotor activity.
Rafales LS; Greenland RD; Zenick H; Goldsmith M; Michaelson IA
Neurobehav Toxicol Teratol; 1981; 3(3):363-7. PubMed ID: 7290291
[TBL] [Abstract][Full Text] [Related]
16. Neurochemical and behavioural changes induced by ascorbic acid and d-amphetamine in the rat.
Desole MS; Anania V; Esposito G; Carboni F; Senini A; Miele E
Pharmacol Res Commun; 1987 Jun; 19(6):441-50. PubMed ID: 3659117
[TBL] [Abstract][Full Text] [Related]
17. Correlative changes of serotonin and catecholamines with pharmacokinetic alterations of imipramine in rat brain.
Sugita S; Kobayashi A; Suzuki S; Yoshida T; Nakazawa K
Eur J Pharmacol; 1989 Jun; 165(2-3):191-8. PubMed ID: 2476322
[TBL] [Abstract][Full Text] [Related]
18. Effect of desipramine and amphetamine on noradrenergic neurotransmission: electrophysiological studies in the rat brain.
Curet O; De Montigny C; Blier P
Eur J Pharmacol; 1992 Oct; 221(1):59-70. PubMed ID: 1333978
[TBL] [Abstract][Full Text] [Related]
19. Interactions of ibogaine and D-amphetamine: in vivo microdialysis and motor behavior in rats.
Maisonneuve IM; Keller RW; Glick SD
Brain Res; 1992 May; 579(1):87-92. PubMed ID: 1623410
[TBL] [Abstract][Full Text] [Related]
20. Desipramine given repeatedly enhances behavioural effects of dopamine and d-amphetamine injected into the nucleus accumbens.
Maj J; Wedzony K; Klimek V
Eur J Pharmacol; 1987 Aug; 140(2):179-85. PubMed ID: 2889605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
